SLC35A2 and glioblastoma: The results revealed that increased expression of SLC35A2 led to the worse prognosis of nine tumors, including kidney renal clear cell carcinoma (KIRC), LIHC, COAD, PAAD, LGG, KIRP, BRCA, uveal melanoma (UVM), and GBM (Figure 4A).